James R. Porter Ph.D.
Net Worth
Last updated:
What is James R. Porter Ph.D. net worth?
The estimated net worth of Dr. James R. Porter Ph.D. is at least $22,034,900 as of 16 Dec 2024. He owns shares worth $14,108,475 as insider, has earned $7,474,545 from insider trading and has received compensation worth at least $451,880 in Nuvalent, Inc..
What is the salary of James R. Porter Ph.D.?
Dr. James R. Porter Ph.D. salary is $451,880 per year as Chief Executive Officer, Pres & Director in Nuvalent, Inc..
How old is James R. Porter Ph.D.?
Dr. James R. Porter Ph.D. is 50 years old, born in 1975.
What stocks does James R. Porter Ph.D. currently own?
As insider, Dr. James R. Porter Ph.D. owns shares in one company:
| Company | Title | Shares | Price per share | Total value |
|---|---|---|---|---|
| Nuvalent, Inc. (NUVL) | Chief Executive Officer, Pres & Director | 188,113 | $75 | $14,108,475 |
What does Nuvalent, Inc. do?
Nuvalent, Inc., a clinical stage biopharmaceutical company, develops therapies for patients with cancer. Its lead product candidates are NVL-520, a brain-penetrant ROS1-selective inhibitor to inhibit ROS1 fusions that express the normal ROS1 kinase domain without any drug-resistant mutations and remain active in the presence of mutations conferring resistance to approved and investigational ROS1 inhibitors, which is under Phase I development; and NVL-655, a brain-penetrant ALK-selective inhibitor, to address the clinical challenges of emergent treatment resistance, central nervous system-related adverse events, and brain metastases that might limit the use of first-, second-, and third-generation ALK inhibitors that is under Phase I/II clinical trial. The company was incorporated in 2017 and is headquartered in Cambridge, Massachusetts.
James R. Porter Ph.D. insider trading
Nuvalent, Inc.
Dr. James R. Porter Ph.D. has made 8 insider trades in 2024, according to the Form 4 filled with the SEC.
The largest trade he's ever made was exercising 27,000 units of NUVL stock on 15 Oct 2024. As of 16 Dec 2024 he still owns at least 188,113 units of NUVL stock.
Nuvalent key executives
Nuvalent, Inc. executives and other stock owners filed with the SEC:
- Dr. James R. Porter Ph.D. (50) Chief Executive Officer, Pres & Director
- Prof. Matthew D. Shair Ph.D. (57) Founder, Head of Scientific Advisory Board & Director